| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/27/2006 | US20060165758 Blunting the postprandial glycemic response by instant feed containing proteins, fats, carbohydrates, neutral soluble dietary fiber (guar gum, pectin, locust bean gum, methylcellulose), and hydrolyzed starch; diabetes |
| 07/27/2006 | US20060165757 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/27/2006 | US20060165756 Method for weight management |
| 07/27/2006 | US20060165735 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165726 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like |
| 07/27/2006 | US20060165706 Antibodies against CTLA4 and uses therefor |
| 07/27/2006 | US20060165701 Agents for the diagnosis and treatment of tumors that expose alerted proteins on the cell surface |
| 07/27/2006 | US20060165607 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/27/2006 | US20060165606 Perforated microstructure; efficiently depositing compound at site of action; minimizing toxic side effects, lowering dosing requirements |
| 07/27/2006 | US20060165594 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 07/27/2006 | US20060165592 Nk cell receptor conjugates for treating malignancies |
| 07/27/2006 | US20060165591 Metal complex-containing pharmaceutical agents |
| 07/27/2006 | US20060163526 high pressure homogenization; high throughput screening |
| 07/27/2006 | DE19853729B4 Verwendung einer im Magen-Darm-Kanal eines Tieres zerfallenden, knetbaren Trägerzusammensetzung Use of a gastro-intestinal tract of an animal decaying, malleable carrier composition |
| 07/27/2006 | DE102005003010A1 Copolymere für kosmetische Mittel, hergestellt in Gegenwart polyfunktioneller Regler Copolymers for cosmetics, in the presence of polyfunctional regulator |
| 07/27/2006 | DE102005002711A1 Herstellung und Verwendung von Monoglyceriden Preparation and use of monoglycerides |
| 07/27/2006 | DE10025671B4 Emulgatoren Emulsifiers |
| 07/27/2006 | CA2604394A1 Hyaluronic acid derivative and neural stem cells for sci and pnt regeneration |
| 07/27/2006 | CA2595909A1 Method of conjugating aminothiol containing molecules to vehicles |
| 07/27/2006 | CA2595902A1 Binding compounds, immunogenic compounds and peptidomimetics of the beta-3 hairpin loop of cystine-knot growth factors |
| 07/27/2006 | CA2595461A1 Method for producing albumin conjugates containing gyrase inhibitors |
| 07/27/2006 | CA2595063A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | CA2593359A1 Direct compression formulation and process |
| 07/27/2006 | CA2593112A1 Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
| 07/26/2006 | EP1683871A2 Nucleic acid ligands and methods for producing the same |
| 07/26/2006 | EP1683812A1 Crosslinked polysaccharide microparticles and method for their preparation |
| 07/26/2006 | EP1683781A2 Polyglycerine partial esters of polyricinoleic acid and polycarbonxylic acids and their use in the preparation of emulsions and dispersions |
| 07/26/2006 | EP1683560A1 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product |
| 07/26/2006 | EP1683529A1 Inclusion compound of porphyrin metal complex and albumin |
| 07/26/2006 | EP1683528A1 Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
| 07/26/2006 | EP1683526A1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| 07/26/2006 | EP1683525A1 Sustained-release phenylalanine derivative preparation for oral administration |
| 07/26/2006 | EP1683524A1 Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative |
| 07/26/2006 | EP1683520A2 Water-soluble paclitaxel produgs |
| 07/26/2006 | EP1683518A1 Pharmaceutical formulation of a stable formoterol-containing propylene glycol solution for use in inhalation therapy and method of preparing it |
| 07/26/2006 | EP1683517A1 Methods for the production of protein particles useful for delivery of pharmacological agents |
| 07/26/2006 | EP1682660A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/26/2006 | EP1682584A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier |
| 07/26/2006 | EP1682583A1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 07/26/2006 | EP1682582A1 Method for the mass production of immunoglobulin constant region |
| 07/26/2006 | EP1682581A1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 07/26/2006 | EP1682552A1 Tocopherol-modified therapeutic drug compounds |
| 07/26/2006 | EP1682491A1 Non-symmetrical gelling agent |
| 07/26/2006 | EP1682186A2 Hyperbranched polymer conjugates via non-enzymatic cleavable linker |
| 07/26/2006 | EP1682185A2 Compositions and methods for treating a posterior segment of an eye |
| 07/26/2006 | EP1682184A1 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 07/26/2006 | EP1682165A1 Use of interferon-tau in medicine |
| 07/26/2006 | EP1682124A1 Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof |
| 07/26/2006 | EP1682119A1 Discodermolide compositions |
| 07/26/2006 | EP1682113A1 Inhibitor imaging agents |
| 07/26/2006 | EP1682094A2 Multilayer dosage form comprising a matrix that influences release of a modulatory substance |
| 07/26/2006 | EP1682092A2 Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer |
| 07/26/2006 | EP1682087A1 Chewable tablet |
| 07/26/2006 | EP1682060A1 Enhancing transdermal administration of hydrophilic drugs |
| 07/26/2006 | EP1682012A2 Composition and apparatus for transdermal delivery |
| 07/26/2006 | EP1503747B1 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
| 07/26/2006 | EP1501534B1 Desmopressin in an orodispersible dosage form |
| 07/26/2006 | EP1387703B1 Fibrin material and method for producing and using the same |
| 07/26/2006 | EP1383539B1 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 07/26/2006 | EP1349578B1 Medicinal association of a biguanine (metformin) and arginine |
| 07/26/2006 | EP1257297B1 Compositions and methods for treatemnt of angiogenesis in pathological lesions |
| 07/26/2006 | EP1242067B1 Calcium formate as a dietary supplement |
| 07/26/2006 | EP1231933B1 An aqueous solution formulation of alpha-interferon |
| 07/26/2006 | EP1216025B1 Dispersion formulations containing lipase inhibitors |
| 07/26/2006 | EP0958812B1 Spherical particle groups, process for preparing the same and spherical particulate pharmaceuticals using the same |
| 07/26/2006 | EP0904100B1 Cationic lipid and receptor ligand-facilitated delivery of biologically active molecules |
| 07/26/2006 | EP0835136B1 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
| 07/26/2006 | EP0788346B1 Emulsified drug delivery systems |
| 07/26/2006 | CN1809607A Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device |
| 07/26/2006 | CN1809594A Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 07/26/2006 | CN1809584A Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof |
| 07/26/2006 | CN1809385A Peg-wortmannin conjugates |
| 07/26/2006 | CN1809384A Chemical combination and method for increasing delivery of coenzyme Q 10 |
| 07/26/2006 | CN1809378A Methods for inhibiting viral replication in vivo |
| 07/26/2006 | CN1809377A Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 07/26/2006 | CN1809376A Liquid stabilized protein formulations in coated pharmaceutical containers |
| 07/26/2006 | CN1809363A Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
| 07/26/2006 | CN1809343A Fast dissolving orally consumable films containing a sucralose as a sweetener |
| 07/26/2006 | CN1807484A Preparation method of glycosyl teminated functionalized polycaprolactone with different branch structure |
| 07/26/2006 | CN1806850A Transdermal drug delivery intensifier composition and its application in externally applied medicine |
| 07/26/2006 | CN1806653A Method for preparing immune polysaccharide and yeast extract by utilizing beer yeast dregs for feeding |
| 07/26/2006 | CN1266096C Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
| 07/26/2006 | CN1265840C Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5 |
| 07/26/2006 | CN1265839C Glycoconjugates obtained from i(candide Utilis) cells and i(Ricinus)i(communis) seeds |
| 07/26/2006 | CN1265838C Injectable veterinary composition for small animals |
| 07/26/2006 | CN1265790C Anti-fungal remedy formulation for external application |
| 07/26/2006 | CN1265787C Liver-targeting mitomycin magnetic nano-particle and its preparation and application in medicine preparation |
| 07/26/2006 | CN1265784C Percutaneous administration preparations |
| 07/25/2006 | US7081518 For the diagnosis and therapy of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin |
| 07/25/2006 | US7081495 Cationic compounds and their use as macro molecular carriers |
| 07/25/2006 | US7081445 Cyclosporin galenic forms |
| 07/25/2006 | US7081354 Interleukin and albumin fusion protein |
| 07/25/2006 | US7081255 Antifungal compositions with improved bioavailability |
| 07/25/2006 | US7081254 For relieving or improving skin roughness and suppressing wrinkling, shows neither any offensive smell nor stickiness, gives users a dry feel upon use, and exhibits controlled foaming upon production and stability |
| 07/25/2006 | US7081252 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 07/25/2006 | US7081251 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 07/25/2006 | US7081250 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 07/25/2006 | US7081249 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 07/25/2006 | US7081246 Stable hydroalcoholic compositions |